Westlake Village BioPartners
Westlake Village BioPartners is venture capital firm focused on incubating and building life sciences companies.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Westlake Village BioPartners Information
Geographic Data
Address: 3075 Townsgate Road
City: Westlake Village
State: CA
Zip: 91361
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$820M
Social
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Westlake Village BioPartners is a venture capital firm focused on incubating and building life sciences companies with entrepreneurs that have the potential to bring transformative therapies and technologies to patients. The Westlake model is built on the founding team’s unique experience in successfully identifying and developing breakthrough therapies and building organizations.
Contact Phone:
+18054659588
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2023 | Akamis Bio | Debt Financing | 0 |
| 12/2020 | Neuron23 | Series B | 80M |
| 11/2021 | Recludix Pharma | Series A | 60M |
| 5/2022 | Sinogen Biopharma | Series A | 10M |
| 4/2021 | Dantari | Funding Round | - |
| 8/2022 | 3T Biosciences | Series A | 0 |
| 12/2020 | Neuron23 | Series A | 33.5M |
| 9/2022 | ArsenalBio | Series B | 0 |
| 9/2022 | ACELYRIN | Series C | 0 |
| 1/2022 | Kyverna Therapeutics | Series B | 0 |
| 10/2019 | Tmunity Therapeutics | Series B | 0 |
| 4/2021 | Capsida | Series A | 50M |
| 3/2022 | Neuron23 | Series C | 0 |
| 1/2020 | Kyverna Therapeutics | Series A | 25M |
| 12/2022 | Dantari | Series A | 0 |
| 5/2022 | Sinogen Biopharma | Series B | 0 |
| 10/2019 | ArsenalBio | Series A | 0 |
| 11/2021 | ACELYRIN | Series B | 0 |
| 9/2021 | Expansion Therapeutics | Series B | 80M |
| 6/2023 | Kate Therapeutics | Series A | 0 |
| 2/2022 | Electra Therapeutics | Series B | 0 |
| 2/2022 | Star Therapeutics | Venture Round | 0 |
| 12/2020 | ACELYRIN | Series A | 8M |
| 6/2023 | Kate Therapeutics | Series A | 0 |
| 1/2023 | Akamis Bio | Debt Financing | 0 |
| 12/2022 | Dantari | Series A | 0 |
| 9/2022 | ACELYRIN | Series C | 0 |
| 9/2022 | ArsenalBio | Series B | 0 |
| 8/2022 | 3T Biosciences | Series A | 0 |
| 5/2022 | Sinogen Biopharma | Series B | 0 |
| 3/2022 | Neuron23 | Series C | 0 |
| 2/2022 | Electra Therapeutics | Series B | 0 |
| 2/2022 | Star Therapeutics | Venture Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
